3.5m EEs, sales -13% (-8% FX), EBIT margin 36.2% (+5.
Rec. PTP -7% vs ABGSCe Vacancies up slightly, property value down -0.
Redeye’s initial view of the newly announced acquisition is positive.
Duell’s Q3 figures were anticipated to be weak following the profit warning.
-20% organic growth in Q2e due to last year's radio order Global military peer estimates remain flat...
Prolight announced that its rights issue was fully subscribed, eliminating near-term financing risk ...
Redeye comments on Kardium’s capital injection of USD250m.
Redeye comments on Genovis’ decision to acquire the remaining 75% of SEQURNA, viewing it as a logica...
Infracom confirmed yesterday that Bredband2 is the underlying investment for its total return swap (...
Redeye comments on Eniro's acquisition of Qwamplify Nordics, a company within digital campaign produ...
Nettoomsättningen uppgick till 45,3 MSEK (43,7) i det fjärde kvartalet (feb-apr) i Vuxen Groups brut...
Q2'25 numbers due on 24 July at 07:45 CET Adj. EBITDA flat, EBIT up 2% for '25e-'27e Unchanged story...
Redeye comments on the cancellation of the Pollen Street agreement, which the company signed in Q3 l...
Q2 report Friday, 18 July at 12:00 CET '25e-'27e adj.
Redeye comments on SSH Communications' announcement that it intends to enter a strategic partnership...
Redeye comments on W5 Solutions announcement of a directed share issue totalling cSEK104m which stre...
Redeye provides commentary on BeammWave's recent developments.
Organic growth could remain close to zero for H1 2025E y/y, but acquisitions should at least offer 6...
Redeye shares its preview of BONESUPPORT’s Q2 2025 results, due July 15.
